Hao_2014_Int.J.Cardiol_178C_253

Reference

Title : Beyond autonomic neuromodulation: Acetylcholinesterase inhibitor against peripheral artery disease - Hao_2014_Int.J.Cardiol_178C_253
Author(s) : Hao CN , Shi YQ , Cheng ZE , Cheng X
Ref : Int J Cardiol , 178C :253 , 2014
Abstract :

The acetylcholinesterase inhibitor (AChEI)-based therapeutic strategies have been shown to have vasculoprotective properties in the animal model of hindlimb ischemia due to its activation of the endothelial cholinergic system. However, little is know about whether other cell types (myocytes, immunocytes) are involved in the AChEI-related therapeutic benefits in peripheral artery disease. Therefore, we review the multiple cell-targeted effects of AChEI on the animal model of hindlimb ischemia and explore its clinical application in angiomyogenesis.

PubMedSearch : Hao_2014_Int.J.Cardiol_178C_253
PubMedID: 25464264

Related information

Citations formats

Hao CN, Shi YQ, Cheng ZE, Cheng X (2014)
Beyond autonomic neuromodulation: Acetylcholinesterase inhibitor against peripheral artery disease
Int J Cardiol 178C :253

Hao CN, Shi YQ, Cheng ZE, Cheng X (2014)
Int J Cardiol 178C :253